Works by Matsushima, Hisashi


Results: 34
    1

    A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer.

    Published in:
    2017
    By:
    • Yuji Hakozaki;
    • Hisashi Matsushima;
    • Jimpei Kumagai;
    • Taro Murata;
    • Tomoko Masuda;
    • Yoko Hirai;
    • Mai Oda;
    • Nobuo Kawauchi;
    • Munehiro Yokoyama;
    • Yukio Homma;
    • Hakozaki, Yuji;
    • Matsushima, Hisashi;
    • Kumagai, Jimpei;
    • Murata, Taro;
    • Masuda, Tomoko;
    • Hirai, Yoko;
    • Oda, Mai;
    • Kawauchi, Nobuo;
    • Yokoyama, Munehiro;
    • Homma, Yukio
    Publication type:
    journal article
    2
    3
    4
    5

    DUCTAL ADENOCARCINOMA OF THE PROSTATE: A REPORT OF 7 CASES.

    Published in:
    Japanese Journal of Urology / Nihon Hinyokika Gakkai Zasshi, 2012, v. 103, n. 5, p. 671, doi. 10.5980/jpnjurol.103.671
    By:
    • Hiramatsu, Kanae;
    • Tsuzaka, Yasuo;
    • Kaneko, Tomoyuki;
    • Matsushima, Hisashi;
    • Homma, Yukio
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Darolutamide in Japanese patients with metastatic hormone‐sensitive prostate cancer: Phase 3 ARASENS subgroup analysis.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 21, p. 1, doi. 10.1002/cam4.70029
    By:
    • Uemura, Motohide;
    • Kikukawa, Hiroaki;
    • Hashimoto, Yasuhiro;
    • Uemura, Hiroji;
    • Mizokami, Atsushi;
    • Kato, Masashi;
    • Matsushima, Hisashi;
    • Kosaka, Takeo;
    • Nakamura, Motonobu;
    • Fukasawa, Satoshi;
    • Smith, Matthew R.;
    • Tombal, Bertrand;
    • Hussain, Maha;
    • Saad, Fred;
    • Fizazi, Karim;
    • Sternberg, Cora N.;
    • Crawford, E. David;
    • Kakiuchi, Haruka;
    • Akiyama, Masanao;
    • Li, Rui
    Publication type:
    Article
    21
    22
    23
    24
    25

    Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 3, p. 578, doi. 10.1007/s10147-020-01824-5
    By:
    • Uemura, Hiroji;
    • Matsushima, Hisashi;
    • Kobayashi, Kazuki;
    • Mizusawa, Hiroya;
    • Nishimatsu, Hiroaki;
    • Fizazi, Karim;
    • Smith, Matthew;
    • Shore, Neal;
    • Tammela, Teuvo;
    • Tabata, Ken-ichi;
    • Matsubara, Nobuaki;
    • Iinuma, Masahiro;
    • Uemura, Hirotsugu;
    • Oya, Mototsugu;
    • Momma, Tetsuo;
    • Kawakita, Mutsushi;
    • Fukasawa, Satoshi;
    • Kobayashi, Tadahiro;
    • Kuss, Iris;
    • Le Berre, Marie-Aude
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34